{"title":"非甾体抗炎药:预防并发症","authors":"Francis Berenbaum","doi":"10.1016/j.monrhu.2022.05.003","DOIUrl":null,"url":null,"abstract":"<div><p>The efficacy of NSAIDs in many rheumatological indications, for analgesic and anti-inflammatory purposes, is no longer in question. However, their prescription may be hindered by co-morbidities that could be aggravated by these drugs, such as coronary artery disease, chronic renal failure or a history of bleeding gastric ulcers. This article provides an update on preventive measures to avoid these complications.</p></div>","PeriodicalId":101125,"journal":{"name":"Revue du Rhumatisme Monographies","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"AINS : la prévention des complications\",\"authors\":\"Francis Berenbaum\",\"doi\":\"10.1016/j.monrhu.2022.05.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>The efficacy of NSAIDs in many rheumatological indications, for analgesic and anti-inflammatory purposes, is no longer in question. However, their prescription may be hindered by co-morbidities that could be aggravated by these drugs, such as coronary artery disease, chronic renal failure or a history of bleeding gastric ulcers. This article provides an update on preventive measures to avoid these complications.</p></div>\",\"PeriodicalId\":101125,\"journal\":{\"name\":\"Revue du Rhumatisme Monographies\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revue du Rhumatisme Monographies\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1878622722000649\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revue du Rhumatisme Monographies","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1878622722000649","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The efficacy of NSAIDs in many rheumatological indications, for analgesic and anti-inflammatory purposes, is no longer in question. However, their prescription may be hindered by co-morbidities that could be aggravated by these drugs, such as coronary artery disease, chronic renal failure or a history of bleeding gastric ulcers. This article provides an update on preventive measures to avoid these complications.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
